Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Icariin Supplementation Suppresses the Markers of Ferroptosis and Attenuates the Progression of Nonalcoholic Steatohepatitis in Mice Fed a Methionine Choline-Deficient Diet
Ji‐Won Choi, Hyewon Choi, Jayong Chung
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12510-12510
Open Access | Times Cited: 18

Showing 18 citing articles:

Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects
Qin Ru, Yusheng Li, Lin Chen, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 50
Ferroptosis inhibitors: past, present and future
Lei Zhang, Yi Luo, Yang Xiang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 17
Drug Advances in NAFLD: Individual and Combination Treatment Strategies of Natural Products and Small-Synthetic-Molecule Drugs
Xing Wan, Jingyuan Ma, He Bai, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 140-140
Open Access | Times Cited: 2
Targeting the regulation of iron homeostasis as a potential therapeutic strategy for nonalcoholic fatty liver disease
Yutong Sui, Xue Geng, Ziwei Wang, et al.
Metabolism (2024) Vol. 157, pp. 155953-155953
Closed Access | Times Cited: 13
Cr(VI) induces ferroptosis in DF-1 cells by simultaneously perturbing iron homeostasis of ferritinophagy and mitophagy
Kaimin Song, Xiaoting Liu, Huiling Xu, et al.
The Science of The Total Environment (2024) Vol. 925, pp. 171818-171818
Closed Access | Times Cited: 8
Examining the Pathogenesis of MAFLD and the Medicinal Properties of Natural Products from a Metabolic Perspective
Yansong Fu, Zhipeng Wang, Hong Qin
Metabolites (2024) Vol. 14, Iss. 4, pp. 218-218
Open Access | Times Cited: 8
Beyond Mortality: Exploring the Influence of Plant Phenolics on Modulating Ferroptosis—A Systematic Review
Nemanja Živanović, Marija Lesjak, Nataša Simin, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 334-334
Open Access | Times Cited: 5
Targeting cell death in NAFLD: mechanisms and targeted therapies
Huili Xu, Shengrong Wan, Ying An, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Coenzyme Q and Selenium Co-Supplementation Alleviate Methionine Choline-Deficient Diet-Induced Metabolic Dysfunction-Associated Steatohepatitis in Mice
Hyewon Choi, Jiwon Choi, Yula Go, et al.
Nutrients (2025) Vol. 17, Iss. 2, pp. 229-229
Open Access
Natural Products as Modulators of Nrf2 Signaling Pathway: Potential Therapeutic Agents for Metabolic Associated Fatty Liver Disease
Xin-Nan Gu, Jinyu Zhang, Hao Ouyang, et al.
(2025)
Closed Access
Ferroptosis in organ fibrosis: Mechanisms and therapeutic approaches
Zhi-Hong Ning, Xiuheng Wang, Yue Zhao, et al.
International Immunopharmacology (2025) Vol. 151, pp. 114341-114341
Closed Access
Exploring the Role of Metabolic Hyperferritinaemia (MHF) in Steatotic Liver Disease (SLD) and Hepatocellular Carcinoma (HCC)
Nikolaos-Andreas Anastasopoulos, Alexandra Barbouti, Anna Goussia, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 842-842
Open Access
Epimedii Folium flavonoids: A double-edged sword effect on the liver, a dual exploration of efficacy and toxicity
Meijun Yue, Yanlu Liu, Xiaoyu Feng, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101269-101269
Open Access
Ferroptosis in Endometriosis: Traditional Chinese Medicine Interventions and Mechanistic Insights
Dazhi Lan, Shuping Huang, Jing Li, et al.
The American Journal of Chinese Medicine (2025), pp. 1-24
Closed Access
ELANE enhances KEAP1 protein stability and reduces NRF2-mediated ferroptosis inhibition in metabolic dysfunction-associated fatty liver disease
Qingqing Yang, Xuan Shen, Yan Luo, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Systematic analysis of the relationship between non-alcoholic fatty liver disease and tissue iron overload: promising areas for the use of polypeptide therapy
I. Yu. Torshin, О. А. Громова, T. E. Bogacheva
Experimental and Clinical Gastroenterology (2024), Iss. 10, pp. 139-152
Open Access | Times Cited: 2
Pharmacological inhibition of p300 ameliorates steatosis, inflammation, and fibrosis in mice with non-alcoholic steatohepatitis
Jung‐Yeon Kim, Ah Young Yang, Kiryeong Kim, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30908-e30908
Open Access
Hepatoprotective effects of an iron chelator, deferoxamine, in a mouse model of metabolic dysfunction-associated fatty liver disease
Jeong Yoon Choi, Jayong Chung
Journal of Nutrition and Health (2024) Vol. 57, Iss. 6, pp. 580-580
Open Access
Page 1

Scroll to top